NCT06237920
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06237920
Title Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab (TURANDORELA)
Acronym TURANDORELA
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Netherlands Cancer Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD

Facility Status City State Zip Country Details
Rijnstate Arnhem Gelderland 6815AD Netherlands Details
Radboud University Medical Center Nijmegen Gelderland 6525GA Netherlands Details
NKI-AVL Amsterdam North Holland 1066CX Netherlands Details
Amsterdam UMC (AUMC) Amsterdam North Holland 1081HV Netherlands Details
Spaarne Gasthuis Hoofddorp North Holland 2143TM Netherlands Details
ISALA Zwolle Overijssel 8025AB Netherlands Details
Leiden University Medical Center (LUMC) Leiden South Holland 2333ZA Netherlands Details
Erasmus Medical Center Rotterdam Zuid_Holland 3015GD Netherlands Details
University Medical Center Utrecht Utrecht 3584CX Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field